• Mashup Score: 0

    Increasing rates of simultaneous heart-kidney (SHK) transplant in the United States exacerbate the overall shortage of deceased donor kidneys (DDK). Current allocation policy does not impose constraints on SHK eligibility, and how best to do so remains unknown. We apply a decision-analytic model to evaluate options for heart transplant (HT) candidates with comorbid kidney dysfunction. We compare…

    Tweet Tweets with this article
    • In this study, authors evaluate transplant strategies for HT candidates with concurrent kidney failure who could be considered for either SHK or HT-only followed by expedited KT (Safety Net strategy) https://t.co/0urFnaEvI5 @amjtransplant

  • Mashup Score: 0

    Alloantibodies are a significant barrier to successful transplantation. While desensitization has emerged, efficacy is limited. Interleukin-6 (IL-6) is an important mediator of inflammation and immune cell activation. Persistent IL-6 production increases the risk for alloantibody production. Here we report our experience with clazakizumab (anti-IL-6) for desensitization of highly HLA-sensitized…

    Tweet Tweets with this article
    • Clazakizumab desensitization, after PLEX + IVIg, appears safe with significant reductions in HLA class I & II antibodies that allowed 18 of 20 patients to receive transplantation with no de novo DSA generation https://t.co/Rjzkp2lHbP @amjtransplant

  • Mashup Score: 0

    Normothermic machine perfusion (NMP) is a novel clinical approach to overcome the limitations of traditional hypothermic organ preservation. NMP can be used to assess and recondition organs prior to transplant and is the subject of clinical trials in solid organ transplantation. In addition, NMP provides an opportunity to deliver therapeutic agents directly to the organ, thus avoiding many…

    Tweet Tweets with this article
    • The 1st report of ex vivo gymnotic delivery of oligonucleotide to the human kidney & demonstrates that Normothermic machine perfusion provides the platform to bind & block detrimental microRNAs in donor kidneys prior to transplantation https://t.co/RKqde4N1N5 @amjtransplant